Common heart drug may slow progression of Huntington's disease

Common heart drug may slow progression of Huntington's diseasebyUniversity of Iowaβ-Blocker Use in Participants With Motor-Manifest Huntington Disease (mmHD) Was Associated With Slower Rate

Updated on: December 16,2024 0

Common heart drug may slow progression of Huntington's disease

Common heart drug may slow progression of Huntington's diseasebyUniversity of Iowaβ-Blocker Use in Participants With Motor-Manifest Huntington Disease (mmHD) Was Associated With Slower Rate

Updated on:December 16,2024 0

Muscle loss could increase dementia risk, study finds

byRadiological Society of North AmericaSchematic diagram of research on how skeletal muscle loss is a risk factor for developing dementia. Credit: Radiological Society of North America (RSNA) an

Updated on: December 16,2024 0

Muscle loss could increase dementia risk, study finds

byRadiological Society of North AmericaSchematic diagram of research on how skeletal muscle loss is a risk factor for developing dementia. Credit: Radiological Society of North America (RSNA) an

Updated on:December 16,2024 0

Algorithm better identifies the origin of a seizure to guide more precise surgical interventions

by Michaela Martinez,Duke UniversityCredit: Duke UniversityEpilepsy is one of the most common neurological diseases in the world, afflicting more than 50 million people. While most forms can be

Updated on: December 16,2024 0

Algorithm better identifies the origin of a seizure to guide more precise surgical interventions

by Michaela Martinez,Duke UniversityCredit: Duke UniversityEpilepsy is one of the most common neurological diseases in the world, afflicting more than 50 million people. While most forms can be

Updated on:December 16,2024 0

Exploring a hidden genetic cause of intellectual disability

byUniversity of the Sunshine CoastMolecular modeling of GTF3C3 variants in the structure of yeast τ131/Tfc4. Credit:Genetics in Medicine(2024). DOI: 10.1016/j.gim.2024.101253A global

Updated on: December 12,2024 0

Exploring a hidden genetic cause of intellectual disability

byUniversity of the Sunshine CoastMolecular modeling of GTF3C3 variants in the structure of yeast τ131/Tfc4. Credit:Genetics in Medicine(2024). DOI: 10.1016/j.gim.2024.101253A global

Updated on:December 12,2024 0

Discovery of molecular mechanism involved in early brain development provides insights into microcephaly pathogenesis

byTohoku UniversityAn overview of Kif23's involvement in embryonic brain development, highlighting how its deficiency disrupts cell division and potentially contribute to microcephaly. Credi

Updated on: December 12,2024 0

Discovery of molecular mechanism involved in early brain development provides insights into microcephaly pathogenesis

byTohoku UniversityAn overview of Kif23's involvement in embryonic brain development, highlighting how its deficiency disrupts cell division and potentially contribute to microcephaly. Credi

Updated on:December 12,2024 0

Understanding the genetic roots of rare mutations in Alzheimer's disease

byVIB (the Flanders Institute for Biotechnology)Hippocampal neurons with staining for endosomes (turquoise and purple) and lysosomes (yellow). When the PSEN2 gene is absent or carries a familial

Updated on: December 11,2024 0

Understanding the genetic roots of rare mutations in Alzheimer's disease

byVIB (the Flanders Institute for Biotechnology)Hippocampal neurons with staining for endosomes (turquoise and purple) and lysosomes (yellow). When the PSEN2 gene is absent or carries a familial

Updated on:December 11,2024 0

Women with ovarian removal have unique risk and resilience factors for Alzheimer disease, research finds

byUniversity of TorontoCredit: Pixabay/CC0 Public DomainResearch published by a team of researchers from the University of Toronto in collaboration with colleagues from the University of Alberta

Updated on: December 11,2024 0

Women with ovarian removal have unique risk and resilience factors for Alzheimer disease, research finds

byUniversity of TorontoCredit: Pixabay/CC0 Public DomainResearch published by a team of researchers from the University of Toronto in collaboration with colleagues from the University of Alberta

Updated on:December 11,2024 0

AI beats experts in predicting future quality of 'mini-organs'

byKyushu UniversityOrganoids predicted by the model to be of high quality (left) expressed RAX (green stain) more widely than organoids predicted to be of low quality (right). Credit: Asano et a

Updated on: December 10,2024 0

AI beats experts in predicting future quality of 'mini-organs'

byKyushu UniversityOrganoids predicted by the model to be of high quality (left) expressed RAX (green stain) more widely than organoids predicted to be of low quality (right). Credit: Asano et a

Updated on:December 10,2024 0

Why do gliomas tend to recur in the brain?

Updated on: December 09,2024 0

Why do gliomas tend to recur in the brain?

Updated on:December 09,2024 0

Microarray in Short Stature Molecular Diagnostic Yield of Exome Sequencing and Chromosomal

Updated on: December 03,2024 0

Microarray in Short Stature Molecular Diagnostic Yield of Exome Sequencing and Chromosomal

Updated on:December 03,2024 0

Repurposed FDA-approved drug could uncover potential treatment for rare genetic disorders

byMcMaster UniversityMass neuronal loss throughout the spinal cord of SD mice at terminal disease stage. Credit:Human Molecular Genetics(2024). DOI: 10.1093/hmg/ddae153In a new study

Updated on: November 29,2024 0

Repurposed FDA-approved drug could uncover potential treatment for rare genetic disorders

byMcMaster UniversityMass neuronal loss throughout the spinal cord of SD mice at terminal disease stage. Credit:Human Molecular Genetics(2024). DOI: 10.1093/hmg/ddae153In a new study

Updated on:November 29,2024 0

European watchdog partially approves new Alzheimer's drug

Credit: Unsplash/CC0 Public DomainEurope's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease, reversing an earlier

Updated on: November 29,2024 0

European watchdog partially approves new Alzheimer's drug

Credit: Unsplash/CC0 Public DomainEurope's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease, reversing an earlier

Updated on:November 29,2024 0